- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| Mi | Sonnet BioTherapeutics Holdings, Inc.: Sonnet BioTherapeutics Completes Enrollment in Phase 1 Study of SON-1010 (IL12-FHAB) as a Monotherapy (SB101) for the Treatment of Solid Tumors | 86 | GlobeNewswire (Europe) | SON-1010 is a targeted immune activation cancer therapy designed to turn 'cold' tumors 'hot' Topline safety data of SB101 Phase 1 study expected by Q4 2024 PRINCETON, NJ, Sept. 18, 2024 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| 12.09. | Aktionäre von Sonnet BioTherapeutics stimmen wichtigen Vorschlägen zu | 4 | Investing.com Deutsch | ||
| 12.09. | Sonnet BioTherapeutics shareholders approve key proposals | 3 | Investing.com | ||
| 09.09. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 04.09. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet BioTherapeutics to Participate in the Virtual Investor Closing Bell Series | 4 | GlobeNewswire (USA) | ||
| 30.08. | Sonnet BioTherapeutics gets extension to meet Nasdaq rule | 5 | Investing.com | ||
| 30.08. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 19.08. | Sonnet BioTherapeutics advances pancreatic cancer treatment | 3 | Investing.com | ||
| 19.08. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 19.08. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet BioTherapeutics Enters into Clinical Collaboration Agreement to Commence Investigator-Initiated and Funded Phase 1/2a Study of SON-1210 in Combination with Chemotherapy for the Treatment of Pancreatic ... | 2 | GlobeNewswire (USA) | ||
| 15.08. | Sonnet BioTherapeutics GAAP EPS of -$0.70 misses by $0.06 | 3 | Seeking Alpha | ||
| 14.08. | Sonnet Biotherapeutics Holdings Inc reports results for the quarter ended in June - Earnings Summary | 2 | Reuters | ||
| 14.08. | Sonnet BioTherapeutics Holdings, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 14.08. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update | 132 | GlobeNewswire (Europe) | Ongoing progress with both clinical trials of lead program, SON-1010, for solid tumors and Platinum-Resistant Ovarian Cancer (PROC) Partnership efforts to support initiation of a Phase 2 clinical... ► Artikel lesen | |
| 09.08. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 24.07. | JTC Team, LLC: Sonnet BioTherapeutics Participates in Virtual Investor "What This Means" Segment Hosted by JTC Team | 316 | ACCESSWIRE | Watch the "What This Means" segment here FRENCHTOWN, NJ / ACCESSWIRE / July 24, 2024 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today released a Virtual... ► Artikel lesen | |
| 24.07. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 24.07. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet BioTherapeutics Reports Encouraging Data from Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy (CIPN) That Support Advancement into Phase 2 Study | 93 | GlobeNewswire (Europe) | Data indicates that SON-080 was well-tolerated at both doses, with no evidence of a pro-inflammatory cytokine responsePain and quality of life survey results suggest the potential for rapid improvement... ► Artikel lesen | |
| 05.07. | Sonnet Bio Therapeutics files to sell 5.77M shares of common stock for holders | 5 | Seeking Alpha |
Seite:
1 2 3 Weiter >>
43 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| KRAFT HEINZ | 31,270 | -0,16 % | Is Kraft Heinz Stock Set for Success Amid a Weak Consumer Market? | ||
| BEYOND MEAT | 5,662 | -0,70 % | Seize the Opportunity: Beyond Meat's New Steak Could Spark Growth | ||
| MODERN PLANT BASED FOODS | 0,170 | -3,41 % | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 09.05.2024 | The following instruments on XETRA do have their first trading 09.05.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 09.05.2024
Aktien
1 CA17965L1004 Clairvest Group Inc.
2... ► Artikel lesen | |
| LUCKIN COFFEE | 17,200 | 0,00 % | Luckin Coffee to buy $2.5 billion worth of Brazilian coffee, official says | ||
| YUM! BRANDS | 115,50 | -0,60 % | Pizza Hut's ResZAmes To Support Job Search | WASHINGTON (dpa-AFX) - Pizza Hut, a subsidiary of Yum! Brands, Inc., is launching 'ResZAmes', a new offering aimed to help professionals deliver their resumes to prospective employers through... ► Artikel lesen | |
| CHIPOTLE MEXICAN GRILL | 51,27 | -0,02 % | Chipotle Is Giving Away Up to $1M in Free Quesadillas for National Quesadilla Day | ||
| KROGER | 49,605 | -0,03 % | Kroger Announces Extension Of Exchange Offers, Consent Solicitations For Albertsons Notes | WASHINGTON (dpa-AFX) - The Kroger Co. (KR) said it has extended the expiration date of the offers to exchange any and all outstanding notes of Albertsons Companies, Inc., New Albertsons, L.P.... ► Artikel lesen | |
| VILLAGE FARMS | 0,805 | +0,88 % | Village Farms CEO sells shares worth over $122,000 | ||
| DOMINOS PIZZA INC | 368,05 | -0,86 % | Domino's Pizza behält "Halten"-Bewertung bei stabiler Kurszielprognose aufgrund des Umsatzwachstums | ||
| BLENDER BITES | 0,593 | -2,31 % | Blender Bites Limited: Blender Bites Reports Second Quarter Fiscal 2024 Unaudited Financial Results | VANCOUVER, British Columbia, July 02, 2024 (GLOBE NEWSWIRE) -- Blender Bites Limited (the "Company", "Blender Bites" or "Blender"), (CSE: BITE, FWB: JL4, WKN: A3DMEJ), announces its unaudited financial... ► Artikel lesen | |
| CAVA GROUP | 128,80 | +2,94 % | Mediterranean Restaurant Cava Hits New Buy Point And New High | ||
| SUEDZUCKER | 11,190 | -0,80 % | Neues Jahrestief: Südzucker stürzt ab: Gewinnwarnung schickt Aktie auf Talfahrt | © Foto: Uwe Anspach/dpaDie Aktie von Südzucker gerät unter Druck: Nach der überraschenden Senkung der Jahresprognose verlor das Papier mehr als 5 Prozent und fiel zwischenzeitlich auf ein neues Jahrestief.... ► Artikel lesen | |
| FIRST WATCH RESTAURANT GROUP | 15,450 | -1,72 % | First Watch Restaurant Group, Inc. Reports Q2 2024 Financial Results | Total revenues increased 19.5% Income from operations margin improved 110 basis points and Restaurant level operating profit margin improved 100 basis points Net income increased 12% to $8.9 million... ► Artikel lesen | |
| SWEETGREEN | 36,975 | +2,79 % | Here's Why You Should Retain Sweetgreen Stock in Your Portfolio Now | ||
| KURA SUSHI USA | 84,53 | -1,49 % | Why Kura Sushi USA Was Such a Tasty Stock This Week |
Das Unternehmen SONNET BIOTHERAPEUTICS HOLDINGS INC kann der Branche Nahrungsmittel/Agrar zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 1,040 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SONNET BIOTHERAPEUTICS HOLDINGS INC finden Sie auf Wallstreet Online.
